Literature DB >> 17489632

Isoprenylated flavonoids from the stem bark of Erythrina abyssinica.

Long Cui1, Derek Tantoh Ndinteh, MinKyun Na, Phuong Thien Thuong, John Silike-Muruumu, Dieudonné Njamen, Joseph Tanyi Mbafor, Zacharias Tanee Fomum, Jong Seog Ahn, Won Keun Oh.   

Abstract

Three new prenylated flavanones, abyssinoflavanones V, VI, and VII (1-3), together with eight known flavanones (4-11) and two chalcones (12-13), were isolated from the stem bark of Erythrina abyssinica. Their structures were elucidated on the basis of spectroscopic and physicochemical analyses. All the isolates, with the exception of 1 and 8, strongly inhibited PTP1B activity in an in vitro assay with IC50 values ranging from 14.2 +/- 1.7 to 26.7 +/- 1.2 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17489632     DOI: 10.1021/np060477+

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Chemical composition and antimicrobial activity of honeybee (Apis mellifera ligustica) propolis from subtropical eastern Australia.

Authors:  Carmelina Flavia Massaro; Jack Bruce Simpson; Daniel Powell; Peter Brooks
Journal:  Naturwissenschaften       Date:  2015-10-31

Review 2.  Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.

Authors:  Cheng-Shi Jiang; Lin-fu Liang; Yue-wei Guo
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

3.  Synthetic production of prenylated naringenins in yeast using promiscuous microbial prenyltransferases.

Authors:  Shota Isogai; Nobuyuki Okahashi; Ririka Asama; Tomomi Nakamura; Tomohisa Hasunuma; Fumio Matsuda; Jun Ishii; Akihiko Kondo
Journal:  Metab Eng Commun       Date:  2021-03-19

Review 4.  Traditional Medicinal Uses, Phytoconstituents, Bioactivities, and Toxicities of Erythrina abyssinica Lam. ex DC. (Fabaceae): A Systematic Review.

Authors:  Samuel Baker Obakiro; Ambrose Kiprop; Elizabeth Kigondu; Isaac K'Owino; Mark Peter Odero; Scolastica Manyim; Timothy Omara; Jane Namukobe; Richard Oriko Owor; Yahaya Gavamukulya; Lydia Bunalema
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-03       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.